189 related articles for article (PubMed ID: 35360105)
21. Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in
Nore KG; Jørgensen MJ; Dyrhol-Riise AM; Jenum S; Tonby K
Front Immunol; 2020; 11():579849. PubMed ID: 33304347
[TBL] [Abstract][Full Text] [Related]
22. Monocyte Subsets: Phenotypes and Function in Tuberculosis Infection.
Sampath P; Moideen K; Ranganathan UD; Bethunaickan R
Front Immunol; 2018; 9():1726. PubMed ID: 30105020
[TBL] [Abstract][Full Text] [Related]
23. Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy.
Chen HM; Ma G; Gildener-Leapman N; Eisenstein S; Coakley BA; Ozao J; Mandeli J; Divino C; Schwartz M; Sung M; Ferris R; Kao J; Wang LH; Pan PY; Ko EC; Chen SH
Clin Cancer Res; 2015 Sep; 21(18):4073-4085. PubMed ID: 25922428
[TBL] [Abstract][Full Text] [Related]
24. Systemic Immunological changes in patients with distinct clinical outcomes during Mycobacterium tuberculosis infection.
Morais-Papini TF; Coelho-Dos-Reis JGA; Wendling APB; do Vale Antonelli LR; Wowk PF; Bonato VLD; Augusto VM; Elói-Santos S; Martins-Filho OA; Carneiro CM; Teixeira-Carvalho A
Immunobiology; 2017 Nov; 222(11):1014-1024. PubMed ID: 28619539
[TBL] [Abstract][Full Text] [Related]
25. Natural killer cell subpopulations in putative resistant individuals and patients with active Mycobacterium tuberculosis infection.
Barcelos W; Sathler-Avelar R; Martins-Filho OA; Carvalho BN; Guimarães TM; Miranda SS; Andrade HM; Oliveira MH; Toledo VP
Scand J Immunol; 2008 Jul; 68(1):92-102. PubMed ID: 18484953
[TBL] [Abstract][Full Text] [Related]
26. Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis.
Leukes V; Walzl G; du Plessis N
Front Immunol; 2020; 11():451. PubMed ID: 32269568
[TBL] [Abstract][Full Text] [Related]
27. Non-classical circulating monocytes in severe obesity and obesity with uncontrolled diabetes: A comparison with tuberculosis and healthy individuals.
Resende DP; da Costa AC; de Souza Rosa LP; Rodrigues AP; Santos ASEA; Cardoso CK; Sousa JD; Kipnis A; Silveira EA; Junqueira-Kipnis AP
Tuberculosis (Edinb); 2019 Jan; 114():30-41. PubMed ID: 30711155
[TBL] [Abstract][Full Text] [Related]
28. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
[TBL] [Abstract][Full Text] [Related]
29. Expansion of Functional Myeloid-Derived Suppressor Cells in Controlled Human Malaria Infection.
Lamsfus Calle C; Fendel R; Singh A; Richie TL; Hoffman SL; Kremsner PG; Mordmüller B
Front Immunol; 2021; 12():625712. PubMed ID: 33815377
[TBL] [Abstract][Full Text] [Related]
30. Diverging biological roles among human monocyte subsets in the context of tuberculosis infection.
Balboa L; Barrios-Payan J; González-Domínguez E; Lastrucci C; Lugo-Villarino G; Mata-Espinoza D; Schierloh P; Kviatcovsky D; Neyrolles O; Maridonneau-Parini I; Sánchez-Torres C; Sasiain Mdel C; Hernández-Pando R
Clin Sci (Lond); 2015 Aug; 129(4):319-30. PubMed ID: 25858460
[TBL] [Abstract][Full Text] [Related]
31. Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α.
Najjar YG; Rayman P; Jia X; Pavicic PG; Rini BI; Tannenbaum C; Ko J; Haywood S; Cohen P; Hamilton T; Diaz-Montero CM; Finke J
Clin Cancer Res; 2017 May; 23(9):2346-2355. PubMed ID: 27799249
[No Abstract] [Full Text] [Related]
32. Selective targeting of different populations of myeloid-derived suppressor cells by histone deacetylase inhibitors.
Hashimoto A; Fukumoto T; Zhang R; Gabrilovich D
Cancer Immunol Immunother; 2020 Sep; 69(9):1929-1936. PubMed ID: 32435850
[TBL] [Abstract][Full Text] [Related]
33. CD163 levels, pro- and anti-inflammatory cytokine secretion of monocytes in children with pulmonary tuberculosis.
Aktas Cetin E; Pur Ozyigit L; Gelmez YM; Cakir E; Gedik AH; Deniz G
Pediatr Pulmonol; 2017 May; 52(5):675-683. PubMed ID: 27685837
[TBL] [Abstract][Full Text] [Related]
34. Impaired dendritic cell differentiation of CD16-positive monocytes in tuberculosis: role of p38 MAPK.
Balboa L; Romero MM; Laborde E; Sabio Y García CA; Basile JI; Schierloh P; Yokobori N; Musella RM; Castagnino J; de la Barrera S; Sasiain MC; Alemán M
Eur J Immunol; 2013 Feb; 43(2):335-47. PubMed ID: 23192690
[TBL] [Abstract][Full Text] [Related]
35. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.
Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N
Front Immunol; 2014; 5():180. PubMed ID: 24795723
[TBL] [Abstract][Full Text] [Related]
36. Increased Levels of Circulating Monocytic- and Early-Stage Myeloid-Derived Suppressor Cells (MDSC) in Acute Myeloid Leukemia.
Lv J; Zhao Y; Zong H; Ma G; Wei X; Zhao Y
Clin Lab; 2021 Mar; 67(3):. PubMed ID: 33739029
[TBL] [Abstract][Full Text] [Related]
37. Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function.
du Plessis N; Loebenberg L; Kriel M; von Groote-Bidlingmaier F; Ribechini E; Loxton AG; van Helden PD; Lutz MB; Walzl G
Am J Respir Crit Care Med; 2013 Sep; 188(6):724-32. PubMed ID: 23885784
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells.
Apodaca MC; Wright AE; Riggins AM; Harris WP; Yeung RS; Yu L; Morishima C
J Immunother Cancer; 2019 Aug; 7(1):230. PubMed ID: 31462270
[TBL] [Abstract][Full Text] [Related]
39. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.
Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A
Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638
[TBL] [Abstract][Full Text] [Related]
40. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
